Company intelligence / Profile preview

Amdipharm

London, United Kingdom

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Amdipharm specializes in commercializing off-patent and niche pharmaceutical products, often in hospital, anaesthesia, or critical care markets. It does not develop novel drugs but revitalizes and manages established medicines considered too small or niche by larger firms[8][9].

Modalities: Small molecule
Industry: Biotech

Partnerships

Multinational pharmaceutical companies in hospital injectable supply[9]

Beyond the preview

Go deeper on Amdipharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amdipharm.

Explore the full profile